scroll
LEARN MORE
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
IREN consensus earnings forecasts – Source Bloomberg
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
PNV $1.31
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
i
PERFORMANCE
i
| SHARE PRICE ACTIVITY | |
|---|---|
| Last (Price) | 1.31 |
| Change | -0.01 (-0.38) |
| Bid / Ask | 1.29 - 1.32 |
| Volume | 1,507,695 |
| Turnover | 1,957,781 |
| Open | 1.31 |
| Day Range | 1.28 - 1.32 |
| VWAP | 1.30 |
| Prev Close | 1.31 |
| Last Trade | 23/05 4:10pm (AEST) |
i
| KEY INFORMATION | |
|---|---|
| Sector | Healthcare |
| Shares Issued | 614,207,085 |
| NTA/Share | 0.00 |
| Last Dividend | 0.00 |
| Dividend Ex Date | 0 |
| Dividend Pay Date | 0 |
i
| CURRENT () | |
|---|---|
| Revenue | |
| EBITDA | |
| Profit | |
| Earnings Per Share (EPS) | 0 |
| Dividend Per Share (DPS) | 0 |
| Yield % | 0.00 |
| Market Cap | 0 |
| Price to Earnings Ratio (P/E) | 153.53 |
i
TARGET PRICE FORECAST
i
| ESTIMATES () | |
|---|---|
| Revenue | 0.00 |
| EBITDA | 0.00 |
| Profit | 0.00 |
| Earnings Per Share (EPS) | 0.00 |
| Dividend Per Share (DPS) | 0.00 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
0.00
Lt Growth Rate
0.00
Recommendation ()
0.00
ACTION
PNV
UPDATED
23/08/2024 09:39
PNV
UPDATED
18/11/2021 09:15
PNV
UPDATED
01/04/2021 08:56
MM is neutral PNV.
Add To Hit List
Business Summary
PolyNovo (PNV) is a biotechnology company. The Company has a portfolio of biodegradeable polymers that have potential for application across numerous medical fields.
Relevant suggested news and content from the site
Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.
chart
IREN consensus earnings forecasts – Source Bloomberg
Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.
Only available to Members
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing.
Click here
